Declaring the existence of human germ-cell mutagens

被引:45
作者
DeMarini, David M. [1 ]
机构
[1] US EPA, Integrated Syst Toxicol Div, Res Triangle Pk, NC 27711 USA
关键词
tobacco smoke; ionizing radiation; air pollution; chemotherapy; heritable effects; TANDEM REPEAT INSTABILITY; TOBACCO-SMOKE; GENETIC TOXICOLOGY; MUTATION-RATES; AIR-POLLUTION; RADIATION; EXPOSURE; GENOTOXICITY; GUIDELINES; DISEASE;
D O I
10.1002/em.21685
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
After more than 80 years of searching for human germ-cell mutagens, I think that sufficient evidence already exists for a number of agents to be so considered, and definitive confirmation seems imminent due to the application of recently developed genomic techniques. In preparation for this, an assessment panel of internationally recognized experts in germ-cell biology and genomics is required to consider either the current evidence now, or impending genomic evidence later, to declare whether an agent is a human germ-cell mutagen. I propose that such a panel be organized under the aegis of the World Health Organization and constructed similarly to the working groups assembled by the International Agency for Research on Cancer for the evaluation of human carcinogens. Support from prominent national and international organizations would be important. Many regulatory agencies already have procedures in place for assessing potential human germ-cell mutagens, and the time is approaching when definitive genomic data in humans will obligate such evaluations. In my view, application of an IARC-type of assessment using available evidence leads to the conclusion that ionizing radiation, cancer chemotherapy, cigarette smoking, and air pollution are Group 1 human germ-cell mutagens. Consideration of the potential adverse health effects to the unexposed offspring of an exposed parent will usher in an entirely new realm of environmental health assessment. I suggest that the long search for human germ-cell mutagens is about to end, and a demonstration of the much-anticipated linkage between heritable disease and environmental factors is poised to begin. Environ. Mol. Mutagen. 2012. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:166 / 172
页数:7
相关论文
共 50 条
  • [41] Central nervous events related to chemotherapy in patients with a germ-cell tumor
    Doehn, C
    Büttner, H
    Fornara, P
    Jocham, D
    AKTUELLE UROLOGIE, 2000, 31 (05) : 271 - 282
  • [42] ACUTE AND LATE VASCULAR COMPLICATIONS FOLLOWING CHEMOTHERAPY FOR GERM-CELL TUMORS
    GERL, A
    CLEMM, C
    WILMANNS, W
    ONKOLOGIE, 1993, 16 (02): : 88 - 92
  • [43] Long-term sexual functioning in germ-cell tumor survivors
    M. Chovanec
    L. Vasilkova
    L. Petrikova
    J. Obertova
    P. Palacka
    K. Rejlekova
    Z. Sycova-Mila
    K. Kalavska
    D. Svetlovska
    B. Mladosievicova
    J. Mardiak
    M. Mego
    BMC Cancer, 20
  • [44] Management of Residual Nonretroperitoneal Disease in Postchemotherapy Nonseminomatous Germ-Cell Tumors
    King, Jennifer M.
    Cheng, Michael
    Kesler, Kenneth
    Ashkar, Ryan
    Althouse, Sandra K.
    Hanna, Nasser H.
    Einhorn, Lawrence H.
    Adra, Nabil
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (23) : 3939 - +
  • [45] SYSTEMIC MASTOCYTOSIS FOLLOWING MEDIASTINAL GERM-CELL TUMOR - AN ASSOCIATION CONFIRMED
    CHARIOT, P
    MONNET, I
    GAULARD, P
    ABDALSAMAD, I
    RUFFIE, P
    DECREMOUX, H
    HUMAN PATHOLOGY, 1993, 24 (01) : 111 - 112
  • [46] Chemotherapy for good-risk metastatic germ-cell testicular tumours
    Culine, S.
    ONCOLOGIE, 2008, 10 (06) : 446 - 450
  • [47] Long-term sexual functioning in germ-cell tumor survivors
    Chovanec, M.
    Vasilkova, L.
    Petrikova, L.
    Obertova, J.
    Palacka, P.
    Rejlekova, K.
    Sycova-Mila, Z.
    Kalavska, K.
    Svetlovska, D.
    Mladosievicova, B.
    Mardiak, J.
    Mego, M.
    BMC CANCER, 2020, 20 (01)
  • [48] OUTCOME ANALYSIS AFTER POSTCHEMOTHERAPY SURGERY IN PATIENTS WITH NONSEMINOMATOUS GERM-CELL TUMORS
    GERL, A
    CLEMM, C
    SCHMELLER, N
    DIENEMANN, H
    LAMERZ, R
    KRIEGMAIR, M
    WILMANNS, W
    ANNALS OF ONCOLOGY, 1995, 6 (05) : 483 - 488
  • [49] THERAPEUTIC MODALITIES FOR GERM-CELL TUMORS OF THE TESTIS, EXCLUDING SURGERY - RADIOTHERAPY - CHEMOTHERAPY
    DUCHATELARD, PP
    MERRER, J
    ANNALES D UROLOGIE, 1992, 26 (02) : 112 - 118
  • [50] SUCCESSFUL TREATMENT OF RECURRENT MALIGNANT GERM-CELL TUMORS - REPORT OF 2 CASES
    MATSUTANI, M
    ASAI, A
    FUJIMAKI, T
    NAKAMURA, O
    ATER, JL
    LEVIN, VA
    GREENBERG, HS
    NEUROSURGERY, 1993, 33 (05) : 901 - 906